Overview

Desmopressin for Bedwetting in Children With SCD

Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
This study assesses if using the medication desmopressin will decrease nightime bedwetting in children with sickle cell disease.
Phase:
Phase 4
Details
Lead Sponsor:
Montefiore Medical Center
Treatments:
Deamino Arginine Vasopressin